4.5 Article

The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning

期刊

JOURNAL OF HYPERTENSION
卷 26, 期 3, 页码 478-485

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/HJH.0b013e3282f331fb

关键词

high glucose concentration; human vascular smooth muscle; vascular inflammation

向作者/读者索取更多资源

Objectives The present study investigated whether high concentrations of D-glucose can trigger pro-inflammatory mechanisms in human aortic smooth muscle cells. Methods The expression and/or the activity of inducible nitric oxide synthase (NOS), the extracellular signal-regulated kinase (ERK)1/2 and nuclear factor (NF)-kappa B were studied in cultured human aortic smooth muscle cells (HASMC) in response to increasing concentrations of D-glucose and/or the inflammatory cytokine interleukin (IL)-1 beta. Results Increasing D-glucose in the medium from 5.5 to 22 mmol/l had no effect on any of these parameters. However, the high concentration of D-glucose did increase iNOS expression in response to low concentrations of IL-1 beta (2.5 and 5 ng/ml), as well as the IL-1 beta-induced activation of both ERK 1/2 and NF-kappa B. D-glucose also enhanced, concentration-dependently, the expression and activity of iNOS induced by co-incubation with IL-1 beta (10 ng/ml). Pretreatment with IL-1 beta sensitized the cells to the subsequent effects of high D-glucose. Conclusions The results indicate that high concentrations of D-glucose exacerbate the pro-inflammatory effects of IL-1 beta. We suggest that the observed association between inflammation and diabetes is the result of elevated D-glucose enhancing a pre-existing inflammatory condition, rather than a direct effect of D-glucose on the production of inflammatory mediators.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

PPAR-γ Gene Expression in Human Adipose Tissue Is Associated with Weight Loss After Sleeve Gastrectomy

Jorge-Luis Torres, Ricardo Usategui-Martin, Lourdes Hernandez-Cosido, Edgar Bernardo, Laura Manzanedo-Bueno, Ignacio Hernandez-Garcia, Ana-Maria Mateos-Diaz, Orlando Rozo, Nuria Matesanz, Daniel Salete-Granado, Antonio-Javier Chamorro, Cristina Carbonell, Marina Garcia-Macia, Rogelio Gonzalez-Sarmiento, Guadalupe Sabio, Luis Munoz-Bellvis, Miguel Marcos

Summary: This study analyzed the expression of PPAR-gamma and miR-27 in adipose tissue of obese patients, finding no significant differences compared to non-obese subjects. The research also identified a negative correlation between pre-operative PPAR-gamma 1 expression and post-operative weight loss, suggesting PPAR-gamma 1 expression as a potential biomarker for response to surgery.

JOURNAL OF GASTROINTESTINAL SURGERY (2022)

Article Geriatrics & Gerontology

Pharmacological Blockade of NLRP3 Inflammasome/IL-1β-Positive Loop Mitigates Endothelial Cell Senescence and Dysfunction

Alejandra Romero, Pilar Dongil, Ines Valencia, Susana Vallejo, Alvaro San Hipolito-Luengo, Guillermo Diaz-Araya, Jose L. Bartha, Maria M. Gonzalez-Arlanzon, Fernando Rivilla, Fernando de la Cuesta, Carlos F. Sanchez-Ferrer, Concepcion Peiro

Summary: This study evaluated the role of IL-1β in promoting endothelial senescence and dysfunction through the NLRP3 inflammasome via NF-κB positive feedback. The results showed that the NLRP3 inflammasome played a crucial role in mediating the detrimental effects of IL-1β, and the inhibitor MCC 950 could alleviate inflammation, cell senescence, and vascular dysfunction.

AGING AND DISEASE (2022)

Review Biochemistry & Molecular Biology

NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically

Ainara Gonzalez-Moro, Ines Valencia, Licia Shamoon, Carlos Felix Sanchez-Ferrer, Concepcion Peiro, Fernando de la Cuesta

Summary: Despite advancements in medicine, mortality from cardiovascular diseases continues to increase due to the pandemic prevalence of obesity and diabetes, as well as the aging global population. The discovery of the potential of anti-inflammatory therapies targeted to IL-1 beta, particularly through the use of the NLRP3 inflammasome blockade, is changing the therapeutic management of cardiovascular diseases. This review discusses the mechanisms by which the NLRP3 inflammasome contributes to vascular disease, with a focus on aging and chronic low-grade inflammation.

ANTIOXIDANTS (2022)

Article Peripheral Vascular Disease

DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2-COX-2-TP Axis and NLRP3 Inflammasome Activation

Ines Valencia, Susana Vallejo, Pilar Dongil, Alejandra Romero, Alvaro San Hipolito-Luengo, Licia Shamoon, Maria Posada, Damian Garcia-Olmo, Raffaelle Carraro, Jorge D. Erusalimsky, Tania Romacho, Concepcion Peiro, Carlos F. Sanchez-Ferrer

Summary: This study found that soluble DPP4 plays an important role in early vascular aging and activates inflammatory mediators in endothelial cells. Endothelial dysfunction in obese patients was associated with increased expression of DPP4, markers of senescence, and inflammation in visceral adipose tissue.

HYPERTENSION (2022)

Article Biochemistry & Molecular Biology

Angiotensin-(1-7), a protective peptide against vascular aging

I Valencia, L. Shamoon, A. Romero, F. De la Cuesta, C. F. Sanchez-Ferrer, C. Peiro

Summary: Vascular aging is a complex process that involves molecular, structural, and functional changes in the vasculature. Preventing or delaying vascular aging is a major health goal, and angiotensin(Ang)-(1-7) has emerged as a promising pharmacological tool for this purpose.

PEPTIDES (2022)

Article Genetics & Heredity

Rapidly Progressing to ESRD in an Individual with Coexisting ADPKD and Masked Klinefelter and Gitelman Syndromes

Ramon Peces, Carlos Peces, Rocio Mena, Emilio Cuesta, Fe Amalia Garcia-Santiago, Marta Ossorio, Sara Afonso, Pablo Lapunzina, Julian Nevado

Summary: This study reports a male patient with ADPKD who also had Klinefelter syndrome and Gitelman syndrome. Through next-generation sequencing and cytogenetic analysis, it was found that the coexistence of these three genetic disorders may act as modifiers with possible synergistic actions that could lead to a rapid progression of ADPKD.
Article Genetics & Heredity

Variability in Phelan-McDermid Syndrome in a Cohort of 210 Individuals

Julian Nevado, Sixto Garcia-Minaur, Maria Palomares-Bralo, Elena Vallespin, Encarna Guillen-Navarro, Jordi Rosell, Cristina Bel-Fenellos, Maria Angeles Mori, Montserrat Mila, Miguel del Campo, Pilar Barruz, Fernando Santos-Simarro, Gabriela Obregon, Carmen Orellana, Harry Pachajoa, Jair Antonio Tenorio, Enrique Galan, Juan C. Cigudosa, Angelica Moresco, Cesar Saleme, Silvia Castillo, Elisabeth Gabau, Luis Perez-Jurado, Ana Barcia, Maria Soledad Martin, Elena Mansilla, Isabel Vallcorba, Pedro Garcia-Murillo, Franco Cammarata-Scalisi, Natalya Goncalves Pereira, Raquel Blanco-Lago, Mercedes Serrano, Juan Dario Ortigoza-Escobar, Blanca Gener, Veronica Adriana Seidel, Pilar Tirado, Pablo Lapunzina

Summary: This study describes a cohort of 210 patients with genetically confirmed Phelan-McDermid syndrome (PMS) and identifies multiple variant types, including small deletions and SHANK3 sequence variants. The findings suggest that SHANK3 plays an important role in PMS, but is probably not solely responsible for all the spectrum features.

FRONTIERS IN GENETICS (2022)

Article Pharmacology & Pharmacy

Resolvin E1 attenuates doxorubicin-induced endothelial senescence by modulating NLRP3 inflammasome activation

Licia Shamoon, Jenaro A. Espitia-Corredor, Pilar Dongil, Marta Menendez-Ribes, Alejandra Romero, Ines Valencia, Guillermo Diaz-Araya, Carlos F. Sanchez-Ferrer, Concepcion Peiro

Summary: Endothelial cell senescence contributes to chronic inflammation and cardiovascular disorders. The drug Doxorubicin induces senescence through the NLRP3 inflammasome, and resolvin E1 can reduce the senescence induced by Doxorubicin and interleukin-1β.

BIOCHEMICAL PHARMACOLOGY (2022)

Article Ophthalmology

Diverse mutational spectrum in the 13q14 chromosomal region in a Brazilian cohort of retinoblastoma

Vanessa Mendonca, Priscila Pereira Sena, Anna Claudia Evangelista dos Santos, Cibele Rodrigues Bonvicino, Patricia Ashton-Prolla, Sidnei Epelman, Sima Esther Ferman, Pablo Lapunzina, Julian Nevado, Nathalia Grigorovski, Clarissa Mattosinho, Hector Seuanez, Fernando Regla Vargas

Summary: Retinoblastoma is a rare childhood tumor and this study identified a wide range of germline chromosomal alterations in retinoblastoma patients. The findings suggest a possible correlation between mutation breakpoint location and tumor outcome and presenting symptom.

EXPERIMENTAL EYE RESEARCH (2022)

Article Biochemistry & Molecular Biology

Novel genes and sex differences in COVID-19 severity

Raquel Cruz, Silvia Diz-de Almeida, Miguel Lopez de Heredia, Ines Quintela, Francisco C. Ceballos, Guillermo M. Lorenzo-Salazar, Rafaela Gonzalez-Montelongo, Manuela Gago-Dominguez, Marta Sevilla Porras, Jair Antonio Tenorio Castano, Julian Nevado, Jose Maria Aguado, Carlos Aguilar, Sergio Aguilera-Albesa, Virginia Almadana, Berta Almoguera, Nuria Alvarez, Alvaro Andreu-Bernabeu, Eunate Arana-Arri, Celso Arango, Maria J. Arranz, Maria-Jesus Artiga, Raul C. Baptista-Rosas, Maria Barreda-Sanchez, Moncef Belhassen-Garcia, Joao F. Bezerra, Marcos A. C. Bezerra, Lucia Boix-Palop, Maria Brion, Ramon Brugada, Matilde Bustos, Enrique J. Calderon, Cristina Carbonell, Luis Castano, Jose E. Castelao, Rosa Conde-Vicente, M. Lourdes Cordero-Lorenzana, Jose L. Cortes-Sanchez, Marta Corton, M. Teresa Darnaude, Alba De Martino-Rodriguez, Victor del Campo-Perez, Aranzazu Diaz de Bustamante, Elena Dominguez-Garrido, Andre D. Luchessi, Rocio Eiros, Gladys Mercedes Estigarribia Sanabria, Maria Carmen Farinas, Uxia Fernandez-Robelo, Amanda Fernandez-Rodriguez, Tania Fernandez-Villa, Belen Gil-Fournier, Javier Gomez-Arrue, Beatriz Gonzalez Alvarez, Fernan Gonzalez Bernaldo de Quiros, Javier Gonzalez-Penas, Juan F. Gutierrez-Bautista, Maria Jose Herrero, Antonio Herrero-Gonzalez, Maria A. Jimenez-Sousa, Maria Claudia Lattig, Anabel Liger Borja, Rosario Lopez-Rodriguez, Esther Mancebo, Caridad Martin-Lopez, Vicente Martin, Oscar Martinez-Nieto, Iciar Martinez-Lopez, Michel F. Martinez-Resendez, Angel Martinez-Perez, Juliana F. Mazzeu, Eleuterio Merayo Macias, Pablo Minguez, Victor Moreno Cuerda, Vivian N. Silbiger, Silviene F. Oliveira, Eva Ortega-Paino, Mara Parellada, Estela Paz-Artal, Ney P. C. Santos, Patricia Perez-Matute, Patricia Perez, M. Elena Perez-Tomas, Teresa Perucho, Mel Lina Pinsach-Abuin, Ericka N. Pompa-Mera, Gloria L. Porras-Hurtado, Aurora Pujol, Soraya Ramiro Leon, Salvador Resino, Marianne R. Fernandes, Emilio Rodriguez-Ruiz, Fernando Rodriguez-Artalejo, Jose A. Rodriguez-Garcia, Francisco Ruiz Cabello, Javier Ruiz-Hornillos, Pablo Ryan, Jose Manuel Soria, Juan Carlos Souto, Eduardo Tamayo, Alvaro Tamayo-Velasco, Juan Carlos Taracido-Fernandez, Alejandro Teper, Lilian Torres-Tobar, Miguel Urioste, Juan Valencia-Ramos, Zuleima Yanez, Ruth Zarate, Tomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, Guillaume Butler-Laporte, Douglas Maya-Miles, Luis Bujanda, Youssef Bouysran, Adriana Palom, David Ellinghaus, Manuel Martinez-Bueno, Selina Rolker, Sara Amitrano, Luisa Roade, Francesca Fava, Christoph D. Spinner, Daniele Prati, David Bernardo, Federico Garcia, Gilles Darcis, Israel Fernandez-Cadenas, Jan Cato Holter, Jesus M. Banales, Robert Frithiof, Stefano Duga, Rosanna Asselta, Alexandre C. Pereira, Manuel Romero-Gomez, Beatriz Nafria-Jimenez, Johannes R. Hov, Isabelle Migeotte, Alessandra Renieri, Anna M. Planas, Kerstin U. Ludwig, Maria Buti, Souad Rahmouni, Marta E. Alarcon-Riquelme, Eva C. Schulte, Andre Franke, Tom H. Karlsen, Luca Valenti, Hugo Zeberg, Brent Richards, Andrea Ganna, Merce Boada, Itziar de Rojas, Agustin Ruiz, Pascual Sanchez-Juan, Luis Miguel Real, Encarna Guillen-Navarro, Carmen Ayuso, Anna Gonzalez-Neira, Jose A. Riancho, Augusto Rojas-Martinez, Carlos Flores, Pablo Lapunzina, Angel Carracedo

Summary: In this study, we identified new candidate genes for COVID-19 severity and provided evidence for genetic disparities among sexes.

HUMAN MOLECULAR GENETICS (2022)

Article Oncology

Clinical Spectrum and Tumour Risk Analysis in Patients with Beckwith-Wiedemann Syndrome Due to CDKN1C Pathogenic Variants

Leila Cabral de Almeida Cardoso, Alejandro Parra, Cristina Rios Gil, Pedro Arias, Natalia Gallego, Valeria Romanelli, Piranit Nik Kantaputra, Leonardo Lima, Juan Clinton Llerena Junior, Claudia Arberas, Encarna Guillen-Navarro, Julian Nevado, Jair Tenorio-Castano, Pablo Lapunzina

Summary: Beckwith-Wiedemann syndrome spectrum (BWSp) is an overgrowth disorder caused by imprinting or genetic alterations at the 11p15.5 locus. Clinical features include overgrowth, macroglossia, neonatal hypoglycaemia, omphalocele, hemihyperplasia, cleft palate, and increased neoplasm incidence. This study examined the clinical and molecular features of all cases of BWSp with CDKN1C variants identified by the Spanish Overgrowth Registry Initiative, with a focus on tumor development in CDKN1C-associated BWSp. The study found that tumor development in patients with BWSp and CDKN1C variants is infrequent but relevant to patient follow-up, supporting the high heterogeneity of BWSp clinical features associated with CDKN1C variants.

CANCERS (2022)

Article Genetics & Heredity

A large, ten-generation family with autosomal dominant preaxial polydactyly/triphalangeal thumb: Historical, clinical, genealogical, and molecular studies

Luis Francisco Gonzalez Alvarez, Jair Tenorio-Castano, Fernando A. Poletta, Fernando Santos-Simarro, Pedro Arias, Natalia Gallego, Ieda Maria Orioli, Stefan Mundlos, Eduardo E. Castilla, Victor Martinez-Glez, Maria Luisa Martinez-Frias, Victor L. Ruiz-Perez, Julian Nevado, Pablo Lapunzina

Summary: We present a large family with 273 individuals, of which 84 people have preaxial polydactyly/triphalangeal thumb caused by a pathogenic variant in the ZRS sequence within exon 5 of the LMBR1 gene. This is the largest family reported so far with this condition.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Article Gastroenterology & Hepatology

Inhibition of Soluble Stem Cell Factor Promotes Intestinal Mucosal Repair

Vicky Garcia-Hernandez, Arturo Raya-Sandino, Veronica Azcutia, Jael Miranda, Matthias Kelm, Sven Flemming, Dorothee Birkl, Miguel Quiros, Jennifer C. Brazil, Charles A. Parkos, Asma Nusrat

Summary: Inflammatory bowel disease (IBD) is a global public health problem and alternative therapies are urgently needed. Previous studies have identified increased expression of stem cell factor (SCF) in inflamed intestinal tissues, but the role of SCF in mediating inflammation and repair has not been explored.

INFLAMMATORY BOWEL DISEASES (2023)

Article Medicine, Research & Experimental

Sialylation regulates neutrophil transepithelial migration, CD11b/CD18 activation, and intestinal mucosal inflammatory function

Veronica Azcutia, Matthias Kelm, Dylan Fink, Richard D. Cummings, Asma Nusrat, Charles A. Parkos, Jennifer C. Brazil

Summary: Polymorphonuclear neutrophils (PMNs) are crucial for clearing microbes and promoting tissue repair, but dysregulated PMN trafficking and tissue damage are common in inflammatory mucosal diseases. The final step of PMN migration in mucosal lined organs involves transepithelial migration (TEpM). CD11b/CD18, a beta 2-integrin, plays a role in PMN intestinal trafficking, and recent studies suggest that terminal fucose and GlcNAc glycans on CD11b/CD18 can be targeted to reduce TEpM. However, the role of sialic acid (Sia) in regulating PMN epithelial influx and inflammatory function is not well understood. This study shows that inhibiting sialidase-mediated removal of alpha 2-3-linked Sia from CD11b/CD18 inhibits PMN migration across intestinal epithelium and affects PMN inflammatory effector functions. Sialidase inhibition also reduces CD11b/CD18 activation and downstream intracellular signaling. These findings suggest that targeting sialylated glycans on CD11b/CD18 could be a novel approach to reducing tissue destruction in inflammatory mucosal diseases.

JCI INSIGHT (2023)

Article Medicine, General & Internal

Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19

Carlos Carpio, Ana Qasem, Antonio Buno, Alberto M. Borobia, Francisco Arnalich, Vega Rey, Teresa Lazaro, Pablo Mariscal, Daniel Laorden, Giorgina Salgueiro, Alberto Moreno, Concepcion Peiro, Oscar Lorenzo, Rodolfo Alvarez-Sala, COVID HULP Working Group, POSTCOVID HULP Working Group

Summary: In this retrospective cohort study, we evaluated KL-6 levels in medium-term post-COVID patients and found that levels of KL-6 were lower in patients with mild COVID-19 compared to those with moderate or severe disease. KL-6 was associated with systemic inflammatory, hepatic enzyme, and thrombosis biomarkers.

JOURNAL OF CLINICAL MEDICINE (2023)

暂无数据